UK and Gulf States Sign Historic Trade Deal Expected to Add Billions to the Economy
Stellantis Turnaround Plan Prediction Market Regulation Oura IPO Filing Key Market Developments
SP 500 Rises on Tech and Healthcare Strength Communication Services Lags
Ferrari Faces Investor Backlash Over First Electric Model Luce
Bloom Energy Shares Surge After 26 Billion FuelCell Deal With AI Data Center Builder Nebius
OIG Report Criticizes USP Canaan Prison Conditions Systemic Issues May Drive Policy Reform
UTI Q1 2026 Earnings EPS Misses Estimates Stock Rises on Potential Optimism
BRBI Q1 2026 Earnings Significant EPS Miss Amid Challenging Environment
RIOT Q1 2026 Earnings EPS Lags Consensus by Wide Margin Stock Climbs 037 Despite Miss
PRVA Q1 2026 Earnings EPS Miss Puts Focus on Cost Management and Growth Trajectory
Armlogi Holding Corp BTOC Q4 2025 Earnings Net Loss Reported Amid Limited Disclosures
SIMO Q1 2026 Earnings EPS Surges 178 Above Estimates But Stock Declines
Global Payments GPN Edges Higher Navigating Support and Resistance Levels
Assured Guaranty Ltd AGO Retreats 226 Amid Broader Market Pressure
Airship AI Holdings Warrants Dip 3 as Support Level Comes into Focus
MFS Municipal Income Trust CMU Holds Steady Near Support Amid Modest Gains
Fundrise Innovation Fund VCX Falls 476 Testing Key Support Levels
New Tax Season Changes Online Sellers and EV Buyers May Find Savings
MNST Q1 2026 Earnings EPS Beats Estimates as Company Delivers Strong Profitability
Vail Resorts MTN Exhibits Strength as Shares Rebound 358
Galectin Therapeutics Q1 2026 Earnings EPS Misses Estimates Stock Rallies on Operational Progress
Corebridge Financial CRBG Q1 2026 Earnings EPS Misses by a Hair Stock Edges Higher
FOXF Q1 2026 Earnings EPS Surges 115 Above Estimates Stock Rises
UXIN Q1 2025 Earnings Loss Per Share Reported Amidst Market Challenges
THRM Q1 2026 Earnings EPS Crushes Estimates with 625 Surprise
LNC Q1 2026 Earnings EPS Surpasses Estimates Despite Absent Revenue Disclosure
PDS Biotechnology Q1 2026 Earnings Narrowed Loss Per Share and Clinical Progress Drive Positive Market Response